Unknown

Dataset Information

0

The interferon-stimulated exosomal hACE2 potently inhibits SARS-CoV-2 replication through competitively blocking the virus entry.


ABSTRACT: Since the outbreak of coronavirus disease 2019 (COVID-19), it has become a global pandemic. The spike (S) protein of etiologic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) specifically recognizes human angiotensin-converting enzyme 2 (hACE2) as its receptor, which is recently identified as an interferon (IFN)-stimulated gene. Here, we find that hACE2 exists on the surface of exosomes released by different cell types, and the expression of exosomal hACE2 is increased by IFNα/β treatment. In particular, exosomal hACE2 can specifically block the cell entry of SARS-CoV-2, subsequently inhibit the replication of SARS-CoV-2 in vitro and ex vivo. Our findings have indicated that IFN is able to upregulate a viral receptor on the exosomes which competitively block the virus entry, exhibiting a potential antiviral strategy.

SUBMITTER: Zhang J 

PROVIDER: S-EPMC8113286 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC7113783 | biostudies-literature
| S-EPMC4301123 | biostudies-other
| S-EPMC8551696 | biostudies-literature
| S-EPMC6414437 | biostudies-literature
| S-EPMC4570769 | biostudies-literature
| S-EPMC7163137 | biostudies-literature
| S-EPMC7203225 | biostudies-literature
| S-EPMC7985356 | biostudies-literature
| S-EPMC7401800 | biostudies-literature
| S-EPMC6701944 | biostudies-literature